Algert Global’s Amneal Pharmaceuticals AMRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.42M | Buy |
1,041,064
+480,281
| +86% | +$3.89M | 0.18% | 172 |
|
2025
Q1 | $4.7M | Buy |
560,783
+114,788
| +26% | +$962K | 0.12% | 298 |
|
2024
Q4 | $3.53M | Sell |
445,995
-2,211
| -0.5% | -$17.5K | 0.08% | 405 |
|
2024
Q3 | $3.73M | Sell |
448,206
-4,518
| -1% | -$37.6K | 0.1% | 347 |
|
2024
Q2 | $2.88M | Buy |
452,724
+46,537
| +11% | +$296K | 0.1% | 349 |
|
2024
Q1 | $2.46M | Buy |
406,187
+99,637
| +33% | +$604K | 0.1% | 343 |
|
2023
Q4 | $1.86M | Buy |
306,550
+62,950
| +26% | +$382K | 0.07% | 436 |
|
2023
Q3 | $1.03M | Buy |
243,600
+54,040
| +29% | +$228K | 0.05% | 565 |
|
2023
Q2 | $588K | Sell |
189,560
-77,242
| -29% | -$240K | 0.03% | 779 |
|
2023
Q1 | $371K | Sell |
266,802
-63,656
| -19% | -$88.5K | 0.02% | 895 |
|
2022
Q4 | $658K | Buy |
330,458
+110,590
| +50% | +$220K | 0.04% | 723 |
|
2022
Q3 | $444K | Sell |
219,868
-17,293
| -7% | -$34.9K | 0.03% | 839 |
|
2022
Q2 | $754K | Sell |
237,161
-54,898
| -19% | -$175K | 0.06% | 594 |
|
2022
Q1 | $1.22M | Buy |
292,059
+190,866
| +189% | +$796K | 0.08% | 437 |
|
2021
Q4 | $485K | Sell |
101,193
-87,844
| -46% | -$421K | 0.06% | 549 |
|
2021
Q3 | $1.01M | Buy |
189,037
+86,177
| +84% | +$460K | 0.13% | 222 |
|
2021
Q2 | $527K | Buy |
102,860
+55,870
| +119% | +$286K | 0.18% | 181 |
|
2021
Q1 | $316K | Buy |
+46,990
| New | +$316K | 0.1% | 290 |
|
2020
Q1 | – | Sell |
-129,020
| Closed | -$622K | – | 410 |
|
2019
Q4 | $622K | Buy |
129,020
+64,630
| +100% | +$312K | 0.19% | 179 |
|
2019
Q3 | $187K | Buy |
+64,390
| New | +$187K | 0.07% | 284 |
|